Skip to content

Efficacy of a Single Preoperative Administration of Action Observation Therapy Associated With Motor Imagery in Patients Undergoing Total Hip Arthroplasty.

Efficacy of a Single Preoperative Administration of Action Observation Therapy Associated With Motor Imagery in Patients Undergoing Total Hip Arthroplasty.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05188560
Enrollment
80
Registered
2022-01-12
Start date
2021-03-01
Completion date
2022-01-01
Last updated
2022-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Orthopedic Disorder

Keywords

Action observation therapy, motor imagery, Hip arthroplasty, functional recovery

Brief summary

Action Observation Therapy (AOT) and Motor Imagery (MI) are two rehabilitation approaches based on Mirror Neuron System (MNS). The MNS refers to a series of neurons able to activate both when one observes an action being performed or when one physically performs the action themselves. Previous studies reported that functional recovery is facilitated by asking patient observing videos with motor content (AOT) and after imagining (MI) the gestures observed. These rehabilitative apporach have been used in particular to promote functional recovery in patients with neuromotor problems, in particular in patients with stroke. To date, few studies have investigated the effectiveness of this therapeutic approach in functional recovery after orthopedic surgery and none of these applied AOT and MI in a single pre-operative session. The objective of the study is to verify whether a single administration consisting of two pre-operative sessions of AOT associated with MI can lead to an improvement of functional recovery in hip arthroplasty patients.

Interventions

OTHERAction observation therapy

Subject is asked to observe videos with motor contents

OTHERmotor imagery

mental simulation of a motor task

Sponsors

Istituto Clinico Humanitas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Total hip arthroplasty (THA) monolateral, first implant * Locomotor autonomy with or without aids before surgery * BMI (regular, overweight, Grade I obesity) * No complications in surgery * Orthopaedic prescription of tolerance load on the limb * Autonomy with aids within the third post-operative day

Exclusion criteria

* Previous total hip replacement on contralateral hip * Dementia or other conditions affecting patient's collaboration * Unresolved clinical complications in the first two post-operative days * Neurological, musculoskeletal or other disorders able to impact on functional recovery * Visual or auditory deficits * Total or partial revisions of THA * Patients assigned to different groups hospitalized in the same room

Design outcomes

Primary

MeasureTime frameDescription
Changes in functional mobility using Timed Up and Go test (TUG).Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.The primary outcome is to investigate whether a single administration consisting of two sessions of AOT and MI performed the day before the total hip arthroplasty may impact on functional recovery in the immediate post-operative period. Functional mobility will be evaluated with Timed Up and Go test.

Secondary

MeasureTime frameDescription
Changes in maximum gait speedBoth groups will be evaluated the day before (T0) and 4 days after (T1) surgery.Changes in maximum gait speed between and within groups will be evaluated with 10 meters-walking test (10 MWT).
Changes in pain using Visual Analogue Scale (VAS)Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.Pain will be assessed with Visual Analogue Scale (VAS 0-10) ranging from 0 (absence of pain) to 10 (maximum pain)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026